Dose-Independent Pharmacokinetics of a New Reversible Proton Pump Inhibitor, KR-60436, after Intravenous and Oral Administration to Rats: Gastrointestinal First-Pass Effect
- 1 August 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (8) , 1592-1603
- https://doi.org/10.1002/jps.10427
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- HPLC ANALYSIS OF A NEW REVERSIBLE PROTON PUMP INHIBITOR, A DIHYDROPYRROLOQUINOLINE DERIVATIVE, IN PLASMA, URINE, AND TISSUE HOMOGENATESJournal of Liquid Chromatography & Related Technologies, 2002
- Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA‐8159, using an equilibrium dialysis techniqueBiopharmaceutics & Drug Disposition, 2000
- Liver and Gastrointestinal First-pass Effects of Azosemide in RatsJournal of Pharmacy and Pharmacology, 1997
- Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutritionJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Kinetics of Aluminum in Rats. Ill: Effect of Route of AdministrationJournal of Pharmaceutical Sciences, 1992
- SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPaseBiochemical Pharmacology, 1991
- Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogs of 4-(arylamino)quinolinesJournal of Medicinal Chemistry, 1990
- New Calculation method of mean Total Body Clearance of Drugs and its Application to Dosage RegimensJournal of Pharmaceutical Sciences, 1980
- New Calculation Method for Mean Apparent Drug Volume of Distribution and Application to Rational Dosage RegimensJournal of Pharmaceutical Sciences, 1979
- Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjectsJournal of Pharmacokinetics and Biopharmaceutics, 1977